Aurobindo Pharma informs about analyst meet

18 Nov 2022 Evaluate
Aurobindo Pharma has informed that Yugandhar Puvvala, Chief Executive Officer of Eugia Pharma Specialities, a wholly owned subsidiary of the Company, will be interacting with officials of Abu Dhabi Investment Authority and Lion Global Investors, at corporate office today November 17, 2022, between 4.00 pm to 5.00 pm. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1175.10 6.20 (0.53%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1311.75
Zydus Lifesciences 879.25
Lupin 2128.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×